Kraig Biocraft Laboratories Confirms Strength and Toughness of Its Commercially Produced Recombinant Spider Silk
ANN ARBOR, Mich., Aug. 13, 2024 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) (“the Company” or “Kraig Labs”), announces today that it has confirmed that the material performance of its commercially produced recombinant spider silk matches the exceptional strength and toughness of the Company’s previous small batch performance testing. The results of this testing open the doors for Kraig Labs to aggressively move forward with commercial production of its proprietary recombinant spider silk.
Related news for (KBLB)
- Worms, Lasers, and Donuts
- Biotech, Ballistics, Blockchain & Battlespace Tech Dominate Today’s Market Narrative
- Kraig Labs Scalable Spider Silk May Unlock the Future of Lightweight Body Armor and Ballistic Protection
- Biotech Breakthroughs, Trans Snack Surges & a Spider Silk Revolution Power Small-Cap Rally
- Biotech Booms, as Innovation-Driven Rally Gains Steam